BioForce Nanosciences Holdings, Inc. (BFNH)
OTCMKTS · Delayed Price · Currency is USD
0.9000
+0.2990 (49.75%)
At close: May 4, 2026

BFNH Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
0.490.490.470.490.5
Operating Expenses
0.490.490.470.490.5
Operating Income
-0.49-0.49-0.47-0.49-0.5
EBT Excluding Unusual Items
-0.49-0.49-0.47-0.49-0.5
Other Unusual Items
-0.8----
Pretax Income
-1.29-0.49-0.47-0.49-0.5
Net Income
-1.29-0.49-0.47-0.49-0.5
Net Income to Common
-1.29-0.49-0.47-0.49-0.5
Shares Outstanding (Basic)
3329292929
Shares Outstanding (Diluted)
3329292929
Shares Change (YoY)
13.44%---79.53%
EPS (Basic)
-0.04-0.02-0.02-0.02-0.02
EPS (Diluted)
-0.04-0.02-0.02-0.02-0.02
EBIT
-0.49-0.49-0.47-0.49-0.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.